Cargando…

Association between abnormal lipid metabolism and tumor

Metabolic Reprogramming is a sign of tumor, and as one of the three major substances metabolism, lipid has an obvious impact. Abnormal lipid metabolism is related to the occurrence of various diseases, and the proportion of people with abnormal lipid metabolism is increasing year by year. Lipid meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chunyu, Wang, Fei, Cui, Lili, Li, Shaoxin, Zhao, Junyu, Liao, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248433/
https://www.ncbi.nlm.nih.gov/pubmed/37305043
http://dx.doi.org/10.3389/fendo.2023.1134154
_version_ 1785055373199147008
author Li, Chunyu
Wang, Fei
Cui, Lili
Li, Shaoxin
Zhao, Junyu
Liao, Lin
author_facet Li, Chunyu
Wang, Fei
Cui, Lili
Li, Shaoxin
Zhao, Junyu
Liao, Lin
author_sort Li, Chunyu
collection PubMed
description Metabolic Reprogramming is a sign of tumor, and as one of the three major substances metabolism, lipid has an obvious impact. Abnormal lipid metabolism is related to the occurrence of various diseases, and the proportion of people with abnormal lipid metabolism is increasing year by year. Lipid metabolism is involved in the occurrence, development, invasion, and metastasis of tumors by regulating various oncogenic signal pathways. The differences in lipid metabolism among different tumors are related to various factors such as tumor origin, regulation of lipid metabolism pathways, and diet. This article reviews the synthesis and regulatory pathways of lipids, as well as the research progress on cholesterol, triglycerides, sphingolipids, lipid related lipid rafts, adipocytes, lipid droplets, and lipid-lowering drugs in relation to tumors and their drug resistance. It also points out the limitations of current research and potential tumor treatment targets and drugs in the lipid metabolism pathway. Research and intervention on lipid metabolism abnormalities may provide new ideas for the treatment and survival prognosis of tumors.
format Online
Article
Text
id pubmed-10248433
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102484332023-06-09 Association between abnormal lipid metabolism and tumor Li, Chunyu Wang, Fei Cui, Lili Li, Shaoxin Zhao, Junyu Liao, Lin Front Endocrinol (Lausanne) Endocrinology Metabolic Reprogramming is a sign of tumor, and as one of the three major substances metabolism, lipid has an obvious impact. Abnormal lipid metabolism is related to the occurrence of various diseases, and the proportion of people with abnormal lipid metabolism is increasing year by year. Lipid metabolism is involved in the occurrence, development, invasion, and metastasis of tumors by regulating various oncogenic signal pathways. The differences in lipid metabolism among different tumors are related to various factors such as tumor origin, regulation of lipid metabolism pathways, and diet. This article reviews the synthesis and regulatory pathways of lipids, as well as the research progress on cholesterol, triglycerides, sphingolipids, lipid related lipid rafts, adipocytes, lipid droplets, and lipid-lowering drugs in relation to tumors and their drug resistance. It also points out the limitations of current research and potential tumor treatment targets and drugs in the lipid metabolism pathway. Research and intervention on lipid metabolism abnormalities may provide new ideas for the treatment and survival prognosis of tumors. Frontiers Media S.A. 2023-05-25 /pmc/articles/PMC10248433/ /pubmed/37305043 http://dx.doi.org/10.3389/fendo.2023.1134154 Text en Copyright © 2023 Li, Wang, Cui, Li, Zhao and Liao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Li, Chunyu
Wang, Fei
Cui, Lili
Li, Shaoxin
Zhao, Junyu
Liao, Lin
Association between abnormal lipid metabolism and tumor
title Association between abnormal lipid metabolism and tumor
title_full Association between abnormal lipid metabolism and tumor
title_fullStr Association between abnormal lipid metabolism and tumor
title_full_unstemmed Association between abnormal lipid metabolism and tumor
title_short Association between abnormal lipid metabolism and tumor
title_sort association between abnormal lipid metabolism and tumor
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248433/
https://www.ncbi.nlm.nih.gov/pubmed/37305043
http://dx.doi.org/10.3389/fendo.2023.1134154
work_keys_str_mv AT lichunyu associationbetweenabnormallipidmetabolismandtumor
AT wangfei associationbetweenabnormallipidmetabolismandtumor
AT cuilili associationbetweenabnormallipidmetabolismandtumor
AT lishaoxin associationbetweenabnormallipidmetabolismandtumor
AT zhaojunyu associationbetweenabnormallipidmetabolismandtumor
AT liaolin associationbetweenabnormallipidmetabolismandtumor